361 related articles for article (PubMed ID: 25045997)
1. Challenges and emerging solutions in the development of compressed orally disintegrating tablets.
Al-Khattawi A; Mohammed AR
Expert Opin Drug Discov; 2014 Oct; 9(10):1109-20. PubMed ID: 25045997
[TBL] [Abstract][Full Text] [Related]
2. Compressed orally disintegrating tablets: excipients evolution and formulation strategies.
Al-khattawi A; Mohammed AR
Expert Opin Drug Deliv; 2013 May; 10(5):651-63. PubMed ID: 23387409
[TBL] [Abstract][Full Text] [Related]
3. Orally disintegrating dosage forms and taste-masking technologies; 2010.
Douroumis D
Expert Opin Drug Deliv; 2011 May; 8(5):665-75. PubMed ID: 21438776
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.
Ghourichay MP; Kiaie SH; Nokhodchi A; Javadzadeh Y
Biomed Res Int; 2021; 2021():6618934. PubMed ID: 34977245
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Cantor SL; Khan MA; Gupta A
Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
[TBL] [Abstract][Full Text] [Related]
6. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
[TBL] [Abstract][Full Text] [Related]
7. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
8. [Orally disintegrating tablets--advantages and drawbacks].
Tho I
Tidsskr Nor Laegeforen; 2012 Feb; 132(4):424-5. PubMed ID: 22353836
[TBL] [Abstract][Full Text] [Related]
9. Recent patents and trends in orally disintegrating tablets.
AlHusban FA; El-Shaer AM; Jones RJ; Mohammed AR
Recent Pat Drug Deliv Formul; 2010 Nov; 4(3):178-97. PubMed ID: 20626334
[TBL] [Abstract][Full Text] [Related]
10. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
12. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
Tafere C; Yilma Z; Abrha S; Yehualaw A
PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology.
Kondo K; Niwa T; Ozeki Y; Ando M; Danjo K
Chem Pharm Bull (Tokyo); 2011; 59(10):1214-20. PubMed ID: 21963629
[TBL] [Abstract][Full Text] [Related]
14. New advances in the characterization of lyophilised orally disintegrating tablets.
Vanbillemont B; Everaert H; De Beer T
Int J Pharm; 2020 Apr; 579():119153. PubMed ID: 32084575
[TBL] [Abstract][Full Text] [Related]
15. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
16. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
Stoltenberg I; Breitkreutz J
Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
[TBL] [Abstract][Full Text] [Related]
17. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous Pravastatin Solid Dispersion Granules Incorporable Into Orally Disintegrating Tablets.
Song H; Moon C; Lee BJ; Oh E
J Pharm Sci; 2018 Jul; 107(7):1886-1895. PubMed ID: 29530714
[TBL] [Abstract][Full Text] [Related]
19. Coated dextrin microcapsules of amlodipine incorporable into orally disintegrating tablets for geriatric patients.
Jang DJ; Bae SK; Oh E
Biomed Pharmacother; 2014 Oct; 68(8):1117-24. PubMed ID: 25458788
[TBL] [Abstract][Full Text] [Related]
20. Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs).
Woyna-Orlewicz K; Brniak W; Tatara W; Strzebońska M; Haznar-Garbacz D; Szafraniec-Szczęsny J; Antosik-Rogóż A; Wojteczko K; Strózik M; Kurek M; Jachowicz R; Mendyk A
Pharm Res; 2023 Dec; 40(12):2947-2962. PubMed ID: 37726407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
